Personalized Medicine

Papers
(The H4-Index of Personalized Medicine is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward59
Pharmacogenomics education in China and the United States: advancing personalized medicine29
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis20
An evidence gap map of the personalized medicine in bladder cancer17
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls16
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing14
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia14
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population13
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients10
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease9
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension9
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness9
0.046406984329224